Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics

Niki BioSolutions' wholly owned subsidiary DiamiR Biosciences has engaged Fios Genomics, an Edinburgh-based bioinformatics and biostatistics specialist, to support the company's Alzheimer's disease program. Fios will provide end-to-end analytical support — data quality assessment, statistical analysis and interpretation of current datasets, and decision-ready reports — to inform target and biomarker prioritization and the design of subsequent validation studies.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.